Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Feb 1;80(3):624-638.
doi: 10.1158/0008-5472.CAN-19-1840. Epub 2019 Nov 13.

Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness

Vivek L Patel  1 Evan L Busch  2   3 Tara M Friebel  2   4 Angel Cronin  4 Goska Leslie  5 Lesley McGuffog  5 Julian Adlard  6 Simona Agata  7 Bjarni A Agnarsson  8   9 Munaza Ahmed  10 Kristiina Aittomäki  11 Elisa Alducci  7 Irene L Andrulis  12   13 Adalgeir Arason  8   14 Norbert Arnold  15 Grazia Artioli  16 Brita Arver  17 Bernd Auber  18 Jacopo Azzollini  19 Judith Balmaña  20 Rosa B Barkardottir  8   14 Daniel R Barnes  5 Alicia Barroso  21 Daniel Barrowdale  5 Muriel Belotti  22 Javier Benitez  23   24 Birgitte Bertelsen  25 Marinus J Blok  26 Istvan Bodrogi  27 Valérie Bonadona  28 Bernardo Bonanni  29 Davide Bondavalli  29 Susanne E Boonen  30 Julika Borde  31   32   33 Ake Borg  34 Angela R Bradbury  35 Angela Brady  36 Carole Brewer  37 Joan Brunet  38 Bruno Buecher  22 Saundra S Buys  39 Santiago Cabezas-Camarero  40 Trinidad Caldés  41 Almuth Caliebe  42 Maria A Caligo  43 Mariarosaria Calvello  29 Ian G Campbell  44   45 Ileana Carnevali  46 Estela Carrasco  20 Tsun L Chan  47   48 Annie T W Chu  47 Wendy K Chung  49 Kathleen B M Claes  50 Gemo Study Collaborators  22 Embrace Collaborators  5 Jackie Cook  51 Laura Cortesi  52 Fergus J Couch  53 Mary B Daly  54 Giuseppe Damante  55 Esther Darder  38 Rosemarie Davidson  56 Miguel de la Hoya  41 Lara Della Puppa  57 Joe Dennis  5 Orland Díez  58 Yuan Chun Ding  59 Nina Ditsch  60 Susan M Domchek  35 Alan Donaldson  61 Bernd Dworniczak  62 Douglas F Easton  5   63 Diana M Eccles  64 Rosalind A Eeles  65 Hans Ehrencrona  66 Bent Ejlertsen  67 Christoph Engel  68   69 D Gareth Evans  70   71 Laurence Faivre  72 Ulrike Faust  73 Lídia Feliubadaló  74 Lenka Foretova  75 Florentia Fostira  76 George Fountzilas  77 Debra Frost  5 Vanesa García-Barberán  41 Pilar Garre  41 Marion Gauthier-Villars  22 Lajos Géczi  27 Andrea Gehrig  78 Anne-Marie Gerdes  79 Paul Gesta  80 Giuseppe Giannini  81 Gord Glendon  12 Andrew K Godwin  82 David E Goldgar  83 Mark H Greene  84 Angelica M Gutierrez-Barrera  85 Eric Hahnen  32   33 Ute Hamann  86 Jan Hauke  31   32   33 Natalie Herold  31   32   33 Frans B L Hogervorst  87 Ellen Honisch  88 John L Hopper  89 Peter J Hulick  90   91 KConFab Investigators  44   45 Hebon Investigators  92 Louise Izatt  93 Agnes Jager  94 Paul James  45   95 Ramunas Janavicius  96 Uffe Birk Jensen  97 Thomas Dyrso Jensen  98 Oskar Th Johannsson  99 Esther M John  100 Vijai Joseph  101 Eunyoung Kang  102 Karin Kast  103 Johanna I Kiiski  104 Sung-Won Kim  105 Zisun Kim  106 Kwang-Pil Ko  107 Irene Konstantopoulou  76 Gero Kramer  108 Lotte Krogh  109 Torben A Kruse  109 Ava Kwong  47   110   111 Mirjam Larsen  31   32   33 Christine Lasset  28 Charlotte Lautrup  112 Conxi Lazaro  74 Jihyoun Lee  113 Jong Won Lee  114 Min Hyuk Lee  113 Johannes Lemke  115 Fabienne Lesueur  22   116   117   118 Annelie Liljegren  17 Annika Lindblom  119   120 Patricia Llovet  41 Adria Lopez-Fernández  20 Irene Lopez-Perolio  41 Victor Lorca  41 Jennifer T Loud  84 Edmond S K Ma  47   48 Phuong L Mai  121 Siranoush Manoukian  19 Veronique Mari  122 Lynn Martin  123 Laura Matricardi  7 Noura Mebirouk  22   116   117   118 Veronica Medici  52 Hanne E J Meijers-Heijboer  124 Alfons Meindl  60 Arjen R Mensenkamp  125 Clare Miller  126 Denise Molina Gomes  127 Marco Montagna  7 Thea M Mooij  128 Lidia Moserle  7 Emmanuelle Mouret-Fourme  22 Anna Marie Mulligan  129   130 Katherine L Nathanson  35 Marie Navratilova  75 Heli Nevanlinna  104 Dieter Niederacher  89 Finn C Cilius Nielsen  25 Liene Nikitina-Zake  131 Kenneth Offit  102   132 Edith Olah  133 Olufunmilayo I Olopade  134 Kai-Ren Ong  135 Ana Osorio  23   24 Claus-Eric Ott  136 Domenico Palli  137 Sue K Park  138   139   140 Michael T Parsons  141 Inge Sokilde Pedersen  142 Bernard Peissel  19 Ana Peixoto  143 Pedro Pérez-Segura  40 Paolo Peterlongo  144 Annabeth Høgh Petersen  98 Mary E Porteous  145 Miguel Angel Pujana  146 Paolo Radice  147 Juliane Ramser  148 Johanna Rantala  149 Muhammad U Rashid  86   150 Kerstin Rhiem  31   32   33 Piera Rizzolo  81 Mark E Robson  132 Matti A Rookus  128 Caroline M Rossing  25 Kathryn J Ruddy  151 Catarina Santos  143 Claire Saule  22 Rosa Scarpitta  152 Rita K Schmutzler  32   33 Hélène Schuster  153 Leigha Senter  154 Caroline M Seynaeve  94 Payal D Shah  35 Priyanka Sharma  155 Vivian Y Shin  110 Valentina Silvestri  81 Jacques Simard  156 Christian F Singer  157 Anne-Bine Skytte  98 Katie Snape  158 Angela R Solano  159 Penny Soucy  155 Melissa C Southey  160   161 Amanda B Spurdle  141 Linda Steele  59 Doris Steinemann  162 Dominique Stoppa-Lyonnet  22   163   164 Agostina Stradella  165 Lone Sunde  97 Christian Sutter  166 Yen Y Tan  167 Manuel R Teixeira  143   168 Soo Hwang Teo  169   170 Mads Thomassen  109 Maria Grazia Tibiletti  46 Marc Tischkowitz  171   172 Silvia Tognazzo  7 Amanda E Toland  173 Stefania Tommasi  174 Diana Torres  86   175 Angela Toss  52 Alison H Trainer  95 Nadine Tung  176 Christi J van Asperen  177 Frederieke H van der Baan  128 Lizet E van der Kolk  87 Rob B van der Luijt  178 Liselotte P van Hest  179 Liliana Varesco  180 Raymonda Varon-Mateeva  136 Alessandra Viel  57 Jeroen Vierstraete  50 Roberta Villa  19 Anna von Wachenfeldt  17 Philipp Wagner  181 Shan Wang-Gohrke  182 Barbara Wappenschmidt  32   33 Jeffrey N Weitzel  183 Greet Wieme  50 Siddhartha Yadav  151 Drakoulis Yannoukakos  76 Sook-Yee Yoon  184 Cristina Zanzottera  19 Kristin K Zorn  121 Anthony V D'Amico  1 Matthew L Freedman  4 Mark M Pomerantz  4 Georgia Chenevix-Trench  141 Antonis C Antoniou  5 Susan L Neuhausen  59 Laura Ottini  81 Henriette Roed Nielsen  109 Timothy R Rebbeck  185   4
Affiliations

Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness

Vivek L Patel et al. Cancer Res. .

Abstract

Pathogenic sequence variants (PSV) in BRCA1 or BRCA2 (BRCA1/2) are associated with increased risk and severity of prostate cancer. We evaluated whether PSVs in BRCA1/2 were associated with risk of overall prostate cancer or high grade (Gleason 8+) prostate cancer using an international sample of 65 BRCA1 and 171 BRCA2 male PSV carriers with prostate cancer, and 3,388 BRCA1 and 2,880 BRCA2 male PSV carriers without prostate cancer. PSVs in the 3' region of BRCA2 (c.7914+) were significantly associated with elevated risk of prostate cancer compared with reference bin c.1001-c.7913 [HR = 1.78; 95% confidence interval (CI), 1.25-2.52; P = 0.001], as well as elevated risk of Gleason 8+ prostate cancer (HR = 3.11; 95% CI, 1.63-5.95; P = 0.001). c.756-c.1000 was also associated with elevated prostate cancer risk (HR = 2.83; 95% CI, 1.71-4.68; P = 0.00004) and elevated risk of Gleason 8+ prostate cancer (HR = 4.95; 95% CI, 2.12-11.54; P = 0.0002). No genotype-phenotype associations were detected for PSVs in BRCA1. These results demonstrate that specific BRCA2 PSVs may be associated with elevated risk of developing aggressive prostate cancer. SIGNIFICANCE: Aggressive prostate cancer risk in BRCA2 mutation carriers may vary according to the specific BRCA2 mutation inherited by the at-risk individual.

PubMed Disclaimer

Conflict of interest statement

Financial support and conflict of interest statements are included at the end of the manuscript.

Figures

Figure 1:
Figure 1:. BRCA1 Pathogenic Sequence Variant Distribution
The x-axis displays the amino acid sequence of the BRCA1 gene. The violet markers indicate the position of PSVs found in the BRCA1 PSV carriers. The vertical position of the markers on the y-axis indicates the frequency of the PSV found in the cohort. Additionally, the blue and tan bars with corresponding axis markers delineate the bins of the BRCA1 PSVs that were created using the “decile” binning strategy and the “functional” binning strategy. Orange and light blue bars indicate the position of breast and ovarian cancer cluster regions, respectively, as identified in the CIMBA breast cancer cohort (Rebbeck et al. JAMA 2015). Lastly, known functional domains within the BRCA1 gene are highlighted. A. Distribution of total BRCA1 PSVs in carriers, B. Distribution of BRCA1 PSVs in carriers who did not develop prostate cancer, C. Distribution of BRCA1 PSVs in carriers who developed prostate cancer.
Figure 2.
Figure 2.. BRCA2 Pathogenic Sequence Variant Distribution
The x-axis displays the amino acid sequence of the BRCA2 gene. The violet markers indicate the position of PSVs found in the BRCA2 PSV carriers. The vertical position of the markers on the y-axis indicates the frequency of the PSV found in the cohort. Additionally, the blue and tan bars with corresponding axis markers delineate the bins of the BRCA2 PSVs that were created using the “decile” binning strategy and the “functional” binning strategy. Orange and light blue bars indicate the position of breast and ovarian cancer cluster regions, respectively, as identified in the CIMBA breast cancer cohort (Rebbeck et al. JAMA 2015). Lastly, known functional domains within the BRCA2 gene are highlighted. A. Distribution of total BRCA2 PSVs in carriers, B. Distribution of BRCA2 PSVs in carriers who did not develop prostate cancer, C. Distribution of BRCA2 PSVs in carriers who developed prostate cancer.

Comment in

References

    1. Giusti RM, Rutter JL, Duray PH, Freedman LS, Konichezky M, Fisher-Fischbein J, et al. A twofold increase in BRCA mutation related prostate cancer among Ashkenazi Israelis is not associated with distinctive histopathology. J Med Genet 2003;40:787–92 - PMC - PubMed
    1. Gallagher DJ, Gaudet MM, Pal P, Kirchhoff T, Balistreri L, Vora K, et al. Germline BRCA mutations denote a clinicopathologic subset of prostate cancer. Clin Cancer Res 2010;16:2115–21 - PMC - PubMed
    1. Kirchhoff T, Kauff ND, Mitra N, Nafa K, Huang H, Palmer C, et al. BRCA mutations and risk of prostate cancer in Ashkenazi Jews. Clin Cancer Res 2004;10:2918–21 - PubMed
    1. Agalliu I, Kwon EM, Salinas CA, Koopmeiners JS, Ostrander EA, Stanford JL. Genetic variation in DNA repair genes and prostate cancer risk: results from a population-based study. Cancer Causes Control 2010;21:289–300 - PMC - PubMed
    1. Agalliu I, Gern R, Leanza S, Burk RD. Associations of high-grade prostate cancer with BRCA1 and BRCA2 founder mutations. Clin Cancer Res 2009;15:1112–20 - PMC - PubMed

Publication types

Grants and funding